JP2016509007A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016509007A5 JP2016509007A5 JP2015556563A JP2015556563A JP2016509007A5 JP 2016509007 A5 JP2016509007 A5 JP 2016509007A5 JP 2015556563 A JP2015556563 A JP 2015556563A JP 2015556563 A JP2015556563 A JP 2015556563A JP 2016509007 A5 JP2016509007 A5 JP 2016509007A5
- Authority
- JP
- Japan
- Prior art keywords
- bone
- biospecific
- agent
- core
- contrast agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1302199.3A GB2510587B (en) | 2013-02-07 | 2013-02-07 | Biospecific agents for bone |
| GB1302199.3 | 2013-02-07 | ||
| PCT/GB2014/050265 WO2014122431A1 (en) | 2013-02-07 | 2014-01-31 | Biospecific agents for bone |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018153482A Division JP6683773B2 (ja) | 2013-02-07 | 2018-08-17 | 骨のための生体特異的な薬剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016509007A JP2016509007A (ja) | 2016-03-24 |
| JP2016509007A5 true JP2016509007A5 (enExample) | 2017-02-23 |
| JP6400026B2 JP6400026B2 (ja) | 2018-10-03 |
Family
ID=47998779
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015556563A Active JP6400026B2 (ja) | 2013-02-07 | 2014-01-31 | 骨のための生体特異的な薬剤 |
| JP2018153482A Expired - Fee Related JP6683773B2 (ja) | 2013-02-07 | 2018-08-17 | 骨のための生体特異的な薬剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018153482A Expired - Fee Related JP6683773B2 (ja) | 2013-02-07 | 2018-08-17 | 骨のための生体特異的な薬剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20150367000A1 (enExample) |
| EP (1) | EP2953682B1 (enExample) |
| JP (2) | JP6400026B2 (enExample) |
| CN (1) | CN105142729A (enExample) |
| CA (1) | CA2898366C (enExample) |
| ES (1) | ES2904260T3 (enExample) |
| GB (1) | GB2510587B (enExample) |
| NZ (1) | NZ710436A (enExample) |
| WO (1) | WO2014122431A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2974611C (en) | 2014-02-27 | 2022-07-12 | Pharmalink Ab | Conjugates of hyaluronan hemiesters with pharmaceutically active substances |
| JP7156665B2 (ja) * | 2017-06-13 | 2022-10-19 | 国立研究開発法人量子科学技術研究開発機構 | 医薬、並びにその製造方法 |
| CN108187143A (zh) * | 2018-02-09 | 2018-06-22 | 福州大学 | 一种兼具磁热效应和原位诱导成骨的多功能复合材料及其制备方法 |
| CN109289119B (zh) * | 2018-09-16 | 2022-05-17 | 华北理工大学 | 一种用于脊柱康复系统的磁性纳米粒子球混合物 |
| US11944982B2 (en) | 2019-06-05 | 2024-04-02 | Battelle Memorial Institute | Polymer-functionalized magnetic particle embodiments for solute separation, and devices and systems for using the same |
| CN111558041A (zh) * | 2020-04-30 | 2020-08-21 | 浙江理工大学 | 羟基磷灰石包裹磁性载药纳米颗粒及其制备方法和在制备骨肉瘤光疗药物中的应用 |
| CN119212686A (zh) * | 2021-09-15 | 2024-12-27 | 国家科学研究中心 | 包含至少一种金属盐和至少一种肽的纳米颗粒 |
| CN117582485B (zh) * | 2023-11-15 | 2024-06-07 | 湛江中心人民医院 | 方格星虫三肽在制备骨质疏松药物中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH694935A5 (de) * | 2000-07-26 | 2005-09-30 | Straumann Holding Ag | Oberflaechenmodifizierte Implantate. |
| AU2003213246A1 (en) * | 2002-02-21 | 2003-09-09 | University Of Virginia Patent Foundation | Bone targeting peptides |
| AU2005209318B2 (en) * | 2004-01-28 | 2010-02-11 | Cytimmune Sciences, Inc. | Functionalized colloidal metal compositions and methods |
| AU2012204100B2 (en) * | 2005-03-21 | 2014-03-06 | The Regents Of The University Of California | Functionalized magnetic nanoparticles and methods of use thereof |
| CN101155549B (zh) * | 2005-03-21 | 2011-11-16 | 加利福尼亚大学董事会 | 官能化磁性纳米颗粒及其使用方法 |
| EP2510936B1 (en) * | 2005-09-28 | 2016-04-13 | The Regents of The University of California | Calcium binding peptides |
| US20100028387A1 (en) * | 2007-06-12 | 2010-02-04 | Ganesan Balasundaram | Biocompatible Coated Nanostructured Titanium Surfaces |
| US8063636B2 (en) * | 2009-05-29 | 2011-11-22 | The Invention Science Fund I, Llc | Systems, devices, methods, and compositions including targeted ferromagnetic structures |
| US9316645B2 (en) * | 2011-10-07 | 2016-04-19 | Brown University | Methods, compositions and kits for imaging cells and tissues using nanoparticles and spatial frequency heterodyne imaging |
-
2013
- 2013-02-07 GB GB1302199.3A patent/GB2510587B/en not_active Expired - Fee Related
-
2014
- 2014-01-31 CA CA2898366A patent/CA2898366C/en active Active
- 2014-01-31 WO PCT/GB2014/050265 patent/WO2014122431A1/en not_active Ceased
- 2014-01-31 EP EP14702931.8A patent/EP2953682B1/en active Active
- 2014-01-31 JP JP2015556563A patent/JP6400026B2/ja active Active
- 2014-01-31 CN CN201480007874.8A patent/CN105142729A/zh active Pending
- 2014-01-31 US US14/765,508 patent/US20150367000A1/en not_active Abandoned
- 2014-01-31 NZ NZ710436A patent/NZ710436A/en not_active IP Right Cessation
- 2014-01-31 ES ES14702931T patent/ES2904260T3/es active Active
-
2018
- 2018-08-17 JP JP2018153482A patent/JP6683773B2/ja not_active Expired - Fee Related
-
2019
- 2019-11-25 US US16/693,780 patent/US11464878B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pucci et al. | Superparamagnetic iron oxide nanoparticles for magnetic hyperthermia: recent advancements, molecular effects, and future directions in the omics era | |
| Estelrich et al. | Iron oxide nanoparticles for magnetically-guided and magnetically-responsive drug delivery | |
| Kakar et al. | Magnetic microspheres as magical novel drug delivery system: A review | |
| US9376690B2 (en) | Templated nanoconjugates | |
| Chen et al. | Increasing the efficacy of stem cell therapy via triple-function inorganic nanoparticles | |
| Qadir et al. | Non-viral delivery system and targeted bone disease therapy | |
| Javed et al. | Cofibrillization of pathogenic and functional amyloid proteins with gold nanoparticles against amyloidogenesis | |
| Zhang et al. | Smart bacterial magnetic nanoparticles for tumor-targeting magnetic resonance imaging of HER2-positive breast cancers | |
| Gonçalves et al. | Magnetic responsive cell-based strategies for diagnostics and therapeutics | |
| Samal et al. | Multilayered magnetic gelatin membrane scaffolds | |
| Zhao et al. | Electrical-charge-mediated cancer cell targeting via protein corona-decorated superparamagnetic nanoparticles in a simulated physiological environment | |
| Sun et al. | Targeting and regulating of an oncogene via nanovector delivery of MicroRNA using patient-derived xenografts | |
| Sizikov et al. | Nonviral locally injected magnetic vectors for in vivo gene delivery: A review of studies on magnetofection | |
| JP2018534932A (ja) | 条件的活性型ポリペプチド | |
| Tang et al. | Nanoparticles as a novel platform for cardiovascular disease diagnosis and therapy | |
| ES2904260T3 (es) | Agentes biospecíficos para huesos | |
| JP2008536907A (ja) | 遺伝子送達 | |
| JP2013522168A5 (enExample) | ||
| Qiu et al. | Strategies for targeting peptide-modified exosomes and their applications in the lungs | |
| Gao et al. | Magnetic nanoparticles for biomedical applications: From diagnosis to treatment to regeneration | |
| Zară-Dănceanu et al. | Magnetic nanoparticle coating decreases the senescence and increases the targeting potential of fibroblasts and adipose-derived mesenchymal stem cells | |
| WO2019028469A1 (en) | FUNCTIONALIZED POLYMER MITOCHONDRIAL COMPOSITIONS AND METHODS OF USE IN CELL TRANSPLANTATION AND FOR MODIFYING METABOLIC PHENOTYPE | |
| Lin et al. | Bone-targeting nanoparticles of a dendritic (aspartic acid) 3-Functionalized PEG-PLGA biopolymer encapsulating simvastatin for the treatment of osteoporosis in rat models | |
| US20220160906A1 (en) | Compositions of and methods of making ferritin-based imaging agents | |
| Karagiannis et al. | Rationally designed tumor-penetrating nanocomplexes |